Recruiting OBSERVATIONAL NCT06060041

IC-8 Apthera IOL New Enrollment Post Approval Study

Sponsor: Bausch & Lomb Incorporated

Conditions Cataract Posterior Capsule Opacification Presbyopia

Updated 8 times since 2023 Last updated: Jan 9, 2026 Started: Sep 8, 2023 Primary completion: Sep 30, 2027 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06060041, this observational or N/A phase trial focuses on Cataract and Posterior Capsule Opacification and remains actively recruiting participants. Sponsored by Bausch & Lomb Incorporated, it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Feb 2025 — Feb 2026 [monthly]

Recruiting
Dec 2024 — Feb 2025 [monthly]

Recruiting
Sep 2024 — Dec 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

▶ Show 3 earlier versions

Dec 2023 — Jul 2024 [monthly]

Recruiting
Nov 2023 — Dec 2023 [monthly]

Recruiting
Oct 2023 — Nov 2023 [monthly]

Recruiting

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch & Lomb Incorporated

Data source: Bausch & Lomb Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bala-Cynwyd, United States , Birmingham, United States , Bountiful, United States , Cape Coral, United States , Dothan, United States , Dover, United States , Indianapolis, United States , Newport Beach, United States , Omaha, United States , Rock Island, United States and 4 more locations